Abstract
This poster, presented at the 16th annual symposium of the International Isotope Society's United Kingdom Group took place at the Wellcome Genome Campus, Hinxton, Cambridge, UK on 1st November 2007, reveals a series of novel iridium (I) complexes of type 2, and highlights their considerable efficiency and general applicability in the field of hydrogen isotope exchange, with levels as low as only 0.5 mol% catalyst loading over short reaction times being required to deliver extremely high levels of labelling.
| Original language | English |
|---|---|
| Pages (from-to) | 257-257 |
| Number of pages | 1 |
| Journal | Journal of Labelled Compounds and Radiopharmaceuticals |
| Volume | 51 |
| Issue number | 5-6 |
| DOIs | |
| Publication status | Published - Apr 2008 |
Keywords
- hydrogen isotope exchange
- potential drug candidate
- metabolic pathway
- iridium
- catalyst
- labelling